Cover Image

Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial

Background: We aimed to describe the mechanisms of immunological recovery and the effects of blocking CCR5 in patients starting ART with advanced HIV-infection. Methods: Sub-study of a randomized, double-blind, clinical trial where patients starting ART with CD4 counts <100cells/uL received mara...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pablo Francisco Belaunzarán-Zamudio (Author), Livio Azzoni (Author), David H. Canaday (Author), Yanink N. Caro-Vega (Author), Brian Clagget (Author), Mohammed S Rassool (Author), Benigno Rodriguez (Author), Ian Sanne (Author), Irini Sereti (Author), Juan G. Sierra-Madero (Author), Michael M. Lederman (Author)
Format:	Book
Published:	Case Western Reserve University, 2017-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

High prevalence of late diagnosis of HIV in Mexico during the HAART era
by: Brenda Crabtree-Ramírez, et al.
Published: (2012)

Result Turnaround Time of RT-PCR for SARS-CoV-2 is the Main Cause of COVID-19 Diagnostic Delay: A Country-Wide Observational Study of Mexico and Colombia
by: Isaac Núñez, et al.
Published: (2022)

Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patients
by: Maura Manion, et al.
Published: (2017)

LYMPHOPENIA: THE MAIN CAUSES
by: N. T. Vatutin, et al.
Published: (2016)

Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification
by: Jintanat Ananworanich, et al.
Published: (2015)

Worsening of Lymphopenia during Apremilast Treatment
by: Antonios G.A. Kolios, et al.
Published: (2016)

Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
by: Gonzalez-Serna A, et al.
Published: (2016)

Recalcitrant warts and lymphopenia in a young male
by: Shaikah Al-Aojan, MBBS, et al.
Published: (2021)

Maraviroc: a review of its use in HIV infection and beyond
by: Woollard SM, et al.
Published: (2015)

Development and evaluation of mucoadhesive bigel containing tenofovir and maraviroc for HIV prophylaxis
by: Margaret O. Ilomuanya, et al.
Published: (2020)

FTY720-derivatives do not induce FTY720-like lymphopenia
by: Ismael Segura-Ulate, et al.
Published: (2017)

Impact of baseline lymphopenia on outcomes of definitive treatment for locally advanced cervical cancer
by: Einsley-Marie Janowski, et al.
Published: (2024)

Radiation-induced lymphopenia and the survival of women with cervical cancer: a meta-analysis
by: Hongming Cao, et al.
Published: (2023)

T-Cell Lymphopenia Detected by Newborn Screening in Two Siblings with an Xq13.1 Duplication
by: Xavier Rios, et al.
Published: (2017)

Electroacupuncture at ST36 (Zusanli) Prevents T-Cell Lymphopenia and Improves Survival in Septic Mice
by: Lv ZY, et al.
Published: (2022)

30LB Maraviroc administration is associated to reversion of latent HIV-1 through NFkB in ART suppressed patients
by: N. Madrid-Elena, et al.
Published: (2016)

Idiopathic CD4 lymphopenia associated with neuroinvasive West Nile disease: Case report and review of the literature
by: Alex McBath, et al.
Published: (2014)

Pre-Existing Lymphopenia Increases the Risk of Hospitalization and Death after SARS-CoV-2 Infection
by: Riccardo Garbo, et al.
Published: (2022)

Newborn Screening for Primary Immunodeficiencies: Focus on Severe Combined Immunodeficiency (SCID) and Other Severe T-Cell Lymphopenias
by: Stephan Borte, et al.
Published: (2015)

No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV infected patients receiving suppressive maraviroc therapy
by: J. Izopet, et al.
Published: (2015)

Maraviroc reactivates HIV with a potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells
by: S. Moreno, et al.
Published: (2019)

Fármacos recentes usados para o tratamento da infecção pelo HIV-1: enfuvirtida, maraviroc, raltegravir e etravirina
by: M.A. Brito
Published: (2011)

CCR5 Antagonist Maraviroc Inhibits Acute Exacerbation of Lung Inflammation Triggered by Influenza Virus in Cigarette Smoke-Exposed Mice
by: Maximiliano Ruben Ferrero, et al.
Published: (2021)

Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab
by: Che YQ, et al.
Published: (2019)

An Under-Recognized Disease: A Rare Case of Idiopathic CD4 Lymphopenia Mislabeled as Primary Ciliary Dyskinesia
by: Fatimah Bukhamseen, et al.
Published: (2022)

Characterization of data-driven geriatric syndrome clusters in older people with HIV: a Mexican multicenter cross-sectional studyResearch in context
by: Virgilio Hernandez-Ruiz, et al.
Published: (2023)

Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort study
by: Yanink Caro-Vega, et al.
Published: (2022)

Heterozygous Mutation in Adenosine Deaminase Gene in a Patient With Severe Lymphopenia Following Corticosteroid Treatment of Autoimmune Hemolytic Anemia
by: Serena I. Tripodi, et al.
Published: (2018)

Dysplasia of Granulocytes in a Patient with HPV Disease, Recurrent Infections, and B Lymphopenia: A Novel Variant of WHIM Syndrome?
by: Viviana Moschese, et al.
Published: (2017)

The CCR5-agonist maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial
by: J. Symons, et al.
Published: (2017)

Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection
by: Jintanat Ananworanich, et al.
Published: (2016)

Lymphopenia With Clinical and Laboratory Features of Combined Immune Deficiency in an 11-Year-Old Female With FANCD2 Variants and Fanconi Anemia
by: Roman Deniskin, et al.
Published: (2019)

Suppression of exercise-induced neutrophilia and lymphopenia in athletes by cystine/theanine intake: a randomized, double-blind, placebo-controlled trial
by: Titchenal C Alan, et al.
Published: (2010)

Correlation between lymphopenia and other hematological parameters with duration of hospital stay as a measure of severity in Covid-19: a retrospective study
by: Ila Singh, et al.
Published: (2024)

Understanding needs and expectations to start effective communities of practice
by: Sanne H. Elbrink, et al.
Published: (2023)

50LB Central nervous system impact of vorinostat, hydroxychloroquine and maraviroc combination therapy followed by treatment interruption in individuals treated during acute HIV infection
by: E. Kroon, et al.
Published: (2016)

Case Report: Multifocal EBV-Associated Diffuse Large B-Cell Lymphoma in a Patient With 6-MP Associated Lymphopenia With TPMT Deficiency
by: Lara Müller-Scholden, et al.
Published: (2022)

Towards a scalable HIV cure research agenda: the role of co-infections
by: Irini Sereti, et al.
Published: (2015)

Reconstitution of Peripheral T Cells by Tissue-Derived CCR4+ Central Memory Cells Following HIV-1 Antiretroviral Therapy
by: Yolanda D. Mahnke, et al.
Published: (2016)

OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection
by: E. Kroon, et al.
Published: (2016)